Clinical Trial Update: A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the dose of WIN-1001X for efficacy and safety in early Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• WIN-1001X

Snippet

Sponsor: Medi Help Line | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN